EPIC |
HLN |
Sector |
Pharma and Biotech |
ISIN |
GB00BMX86B70 |
Market Sector |
MAIN |
Market Segment |
SET1 |
Main Indices |
FTSE 100, FTSE 350, FTSE All-Share |
Country of register |
Great Britain |
Currency |
British Pound |
Market Cap |
£31,333m |
NMS |
7,500 |
Shares in issue |
8,906m |
Date Listed |
n/a |
|
Interim |
Final |
Ex-Div |
14-Aug-25 |
24-Apr-25 |
Paid |
18-Sep-25 |
05-Jun-25 |
Amount |
2.20p |
4.60p |
16:52 |
949 @ 351.80p |
16:37 |
111 @ 351.80p |
16:37 |
1,000 @ 351.80p |
16:35 |
554 @ 351.80p |
16:35 |
4,226 @ 351.80p |
CEO |
Brian McNamara |
CFO |
Dawn Allen |
Top of Page
You are here:
research